In the Tumor Profiler proof-of-concept observational study, a multiomics approach for profiling tumors from patients with melanoma was feasible, returning data within 4 weeks and informing treatment recommendations in 75% of cases.
- Nicola Miglino
- Nora C. Toussaint
- Andreas Wicki